Icosavax Inc (ICVX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ICVX Annual Cash Flow →
From Icosavax Inc through Sep 30 2022, changes in Sep 30 2023's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
9 Months
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Operating Activities
Income-73.10
Depreciation & amortization2.07
Amortization of Other Assets-3.63
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation18.91
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Non Cash Interest Expense-
Change In Fair Value Of Embedded Derivative Liability-
Non Cash Lease Expense-
Increase Decrease In Operating Lease Liability-1.25
Increase Decrease In Prepaid And Other Current Assets-1.94
Increase Decrease In Right Of Use Assets0.27
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-1.32
Increase (Decrease) in Accrued Liabilities0.85
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-1.23
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.53
Discontinued operations0.00
Net Cash flow from Operating Activities-59.84
Investing Activities
Capital Expenditures-2.28
Sale of Capital Items0.00
Short-term Investments Proceeds-2.52
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-4.81
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock67.98
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment Of Deferred Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities67.98
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-62.13
Total Cash Flow3.33
4 historic quarters locked

Sign in to unlock the full Icosavax Inc cash flow history.

About Icosavax Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-063857

Figures are derived from filed reports and may be restated. Historical data is subject to revision.